Wiriyarat W et al. Erythrocyte binding preference of 16 subtypes of low pathogenic avian influenza and 2009 pandemic influenza A (H1N1) viruses. Vet Microbiol. 2010 Dec 15;146(3-4):346-9. Epub 2010 May 31.
Krauss S et al. Coincident Ruddy Turnstone migration and horseshoe crab spawning creates an ecological “Hot Spot” for influenza viruses. Proc Biol Sci. 2010 Nov 22; 277(1699):3373-9.
Perera KV et al. Influenza virus infections among a sample of hospital attendees in Ragama, Sri Lanka. Ceylon Med J. 2010 Jun;55(2):40-4.
Ellebedy AH et al. Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets. Vaccine. 2010 Sep 15.
Mueller SN et al. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections. J Immunol. 2010 Aug 15;185(4):2182-90. Epub 2010 Jul 16.
Andrianov AK et al. PCPP formulated H5N1 influenza vaccine displays improved stability and dose-sparing effect in lethal challenge studies. J Pharm Sci. 2010 Oct 19. [Epub ahead of print].
Ellebedy E et al. Contemporary seasonal A (H1N1) influenza virus infection primes for a more robust response to split inactivated pandemic A(H1N1) vaccination in ferrets. Clin Vaccine Immunol. 2010 Dec;17(12):1998-2006. Epub 2010 Oct 20.
Stoner TD et al. Antiviral Susceptibility of Avian and Swine Influenza of the N1 Neuraminidase Subtype. J Virol, 2010, 84(19):9800-9809.
Delogu M et al. Can preening contribute to influenza A virus infection in wild waterbirds? PLoS One. 2010 Jun 25;5(6):e11315.
Forrest HL, Webster RG. Perspectives on influenza evolution and the role of research. Anim Health Res Rev. 2010 Jun;11(1):3-18.
Lekcharoensuk P et al. First whole genome characterization of swine influenza virus subtype H3N2 in Thailand. Vet Microbiol. 2010 Oct 26;145(3-4):230-44. Epub 2010 Apr 24.
Vijaykrishna D et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 2010; 328: 1529.
Kim JK et al. The puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11044-9. Epub 2010 Jun 1.
Reid SM et al. First reported incursion of highly pathogenic notifiable avian influenza A H5N1 viruses from clade 2.3.2 into European poultry. Transboundary and Emerging Diseases Volume 58, Issue 1, pages 76–78, February 2011.
Negovetich NJ, Webster RG. Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J Virol. 2010 Sep;84(18):9369-76. Epub 2010 Jul 7.
Moseley CE et al. Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice. Influenza Other Respi Viruses. 2010 Sep;4(5):307-11.
Carlson C et al. Transforming Growth Factor- β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis. PLoS Pathog. 2010 Oct 7;6(10). pii: e1001136.
Sundararajan A et al. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 2010 Oct;88(1):1-9. Epub 2010 Jul 14.
Chu DK et al. Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans. J Gen Virol. 2010 Oct; 91(Pt 10):2457-62.
Duan S et al. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathogens, 29; 6(7): e1001022, 2010.
Boltz DA et al. Drugs in development for Influenza. Drugs, 30; 70(11): 1349-1362, 2010.
Carr S et al. Oseltamivir resistant influenza A and B viruses pre- and post antiviral therapy in children with cancer. Pediatr Infect Dis J. 2010 Nov 2. [Epub ahead of print]
Lee SMY et al. Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respiratory Research 2010, 11:147 doi:10.1186/1465-9921-11-147.
Peiris JS et al. Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol. 2010 Aug;22(4):475-81. Epub 2010 Jun 30.
Cheung TK et al. Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format. J Virol Methods. 165:302-4.
Poon LL et al. Rapid detection of reassortment of pandemic H1N1/2009 influenza virus. Clin Chem. 56:1340-4.
Sanders CJ et al. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 2010 Sep 17.
Dash P et al. Paired analysis of TCRα and TCRβ chains at the single-cell level in mice. J Clin Invest. 2011;121(1):288–295. doi:10.1172/JCI44752.
Kanneganti TD. Central roles of NLRs and inflammasomes in viral infection. 10(10):688-98. Nature Reviews Immunology.
Aguilar-Yáñez JM et al. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 5: e11694, 2010.
DuBois RM et al. The receptor-binding domain of influenza virus hemagglutinin protein produced in Escherichia coli folds into its native, immunogenic structure. J Virol. doi:10.1128/JVI.01412-10.
Ma W et al. Rapid detection of the pandemic H1N1 virus by real-time and gel-based RT-PCR assays. Influenza and other respiratory viruses. 2010, DOI:10.1111/j.1750-2659.2010.00180.x.
Wu JT et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010 Nov 15;51(10):1184-91.
Ilyushina NA et al. Extensive Mammalian Ancestry of Pandemic (H1N1) 2009 Virusancestry. Emerging Infectious Diseases, 2010, 16:314-317.
Ilyushina NA et al. Does pandemic A/H1N1 virus have the potential to become more pathogenic? MBIO doi: 10.1128/mBio.00249-10 16 November 2010 mBio vol. 1 no. 5 e00249-10
Ilyushina NA et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol. 2010 Sep;84(17):8607-16. Epub 2010 Jun 30.
Peacey M et al. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis. 2010 Oct;16(10):1618-20. PubMed PMID: 20875294.
Forgie SE et al. Swine Outbreak of Pandemic Influenza A Virus on a Canadian Research Farm Supports Human-to-Swine Transmission. Clin Infect Dis. 2011 Jan;52(1):10-8. PubMed PMID: 21148514.
Loeb M et al. Pandemic (H1N1) 2009 risk for nurses after trivalent vaccination. Emerg Infect Dis. 2010 Apr;16(4):719-20. PubMed PMID:20350398.
Kim JK et al. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. PNAS June 15, 2010 vol. 107 no. 24 11044-11049
Govorkova EA et al. Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model. J Virol. doi:10.1128/JVI.00689-10.
Boon AC et al. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 influenza mouse model. J Virol, August 2010, p. 7662-7667, Vol. 84, No. 15 publisher]
Marjuki H et al.. Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol. 2010 Jun;155(6):925-34. Epub 2010 Apr 11.
Krauss S and Webster RG. Avian influenza surveillance and wild birds: Past and Present. 2010. Avian Diseases, 2010, 54:394-398.
Boltz DA et al.. Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol. 2010 Apr;91(Pt 4):949-59.
Huang K et al. Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China. J Virol, July 2010, p. 6978-6986, Vol. 84, No. 14
Silversides D et al.. Species origin of the St. Jude porcine lung epithelial cell line (SJPL) made available to researchers. J Virol. July 2010, p. 6978-6986, Vol. 84, No. 14.
Barber MR et al.. Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5913- 8.
Boon J et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. 2009. J Virol. 83:10417-26.
Chen H et al.. Serologic survey of pandemic (H1N1) virus, Guangxi Province, China. Emerging Infectious Diseases 15: 1849–1850.
Ilyushina NA. Effect of neuraminidase inhibitor–resistant mutations on fitness and pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets. PLoS Pathog 6(5): e1000933. doi:10.1371/journal.ppat.1000933
Lee SMY et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS ONE 4(12): e8072. doi:10.1371/journal.pone.0008072.
Chan MC et al. Tropism and Innate Host Responses of the 2009 Pandemic H1N1 Influenza Virus in ex Vivo and in Vitro Cultures of Human Conjunctiva and Respiratory Tract. Am J Pathol. 2010 Jan 28. On line.
Rutigliano JA et al.. Protective memory responses are modulated by priming events prior to challenge. J Virol. 2010 Jan; 84(2):1047-56. Epub 2009 Nov 4. PMCID: PMC2798378.
Thomas PG et al.. Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge. J Immunol. 2010 Feb 15; 184(4):1721-7. Epub 2010 Jan 8. PMCID: PMC2826830.
Masopust D et al.. Dynamic T cell migration program provides resident memory within intestinal epithelium. 2010. J Exp Med. Mar 15; 207(3):553-64.
Vanderlinden E et al.. Novel inhibitors of influenza virus fusion: Structure-activity relationship and interaction with the viral hemagglutinin. J Virol, 2010; 84:4277-4288.
Ma W, Richt JA. Swine influenza vaccines: current status and future perspectives. Anim Health Res Rev. 2010 Jun;11(1):81-96. Epub 2010 May 13.
Ma W et al.. Viral reassortment and transmission after coinfection of pigs with classical H1N1 and triple reassortant H3N2 swine influenza viruses. J Gen. Virol. 2010 : vir.0.021402-0v1-vir.0.021402-0.
McCullers JA et al. Recipients of vaccine against the 1976 “swine flu” have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis. 2010 Jun 1;50(11):1487-92.
Cowling BJ et al. Comparative Epidemiology of pandemic and seasonal influenza A in 2009 within households. N Engl J Med. 2010 Jun 10;362(23):2175-84.
Ilyushina NA et al. Extensive mammalian ancestry of pandemic (H1N1) 2009 virus. Emerging Infectious Diseases, 2010, 16:314-317.
Ducatez MF et al. Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants. J Virol Methods. 2010 May 5. [Epub ahead of print].
Zhu H et al.. Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology. doi:10.1016/j.virol.2010.02.024.
Alvarez et al. Specific Recognition of Influenza A/H1N1/2009 Antibodies in Human Serum: A Simple Virus-Free ELISA Method. PLoS ONE 5(4): e10176. doi:10.1371/journal.pone.0010176.
Aamir UB et al. Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan. Virology 390(2):212-20, 2009 Aug 1.
Boon AC et al. Antigenic cross-reactivity among H5N1 viruses. Curr Top Microbiol Immunol 2009 333:25-40.
Ellebedy AH et al. Influenza Vaccines. Vaccine 2009 27: Suppl 4:D65-8.
Cheung PP et al.. Identifying the species-origin of fecal droppings used for avian influenza virus surveillance in wild-birds. Journal of Clinical Virolology 2009; 46: 90–93.
Berhane Y et al. Highly pathogenic avian influenza virus A (H7N3) in domestic poultry, Saskatchewan, Canada, 2007. Emerg Infect Dis. 2009;15:1492-5.
Yen HL et al.. Pandemic influenza as a current threat. Curr Top Microbiol Immunol. 2009; 333:3-24.
Chaichoune K et al.. Indigenous sources of 2007-2008 H5N1 avian influenza outbreaks in Thailand. J Gen Virol. 2009 Jan;90(Pt 1):216-22.
ML Russell et al. Protocol: Transmission and prevention of influenza in Hutterites: Zoonotic Transmission of Influenza A: Swine & Swine workers. BMC Public Health.
Brockwell-Staats C et al. Diversity of Influenza Viruses in Swine and the Emergence of a Novel Human Pandemic Influenza A (H1N1). Influenza Other Resp Viruses. 2009; 3:207-213.
Song MS et al. The polymerase acidic protein gene of influenza A virus contributes to pathogenicity in a mouse model. J Virol. Sep 30 2009 Epub ahead of print.
Ma W et al. Identification and characterization of a highly virulent triple reassortant H1N1 swine influenza virus in the United States. Virus Genes, 2009.
Smith GJD et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122-1125.
Guan Y et al. Molecular epidemiology of H5N1 avian influenza. Rev Sci Tech. 2009 28:39-47.
Kim JK et al. Ducks: the "Trojan Horse" of H5N1 influenza. Influenza and Other Respiratory Viruses. Influenza and Other Respiratory Viruses, 3, 121-128.
Boltz DA et al. Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR. Arch Virol. 2009; 154(6):939-44.
Bahgat MM et al. Characterization of an avian influenza virus H5N1 Egyptian isolate. J Virol Methods. 2009:159:244-50.
Smith GJD et al. Dating the emergence of pandemic influenza viruses. Proceedings of the National Academy of Science USA 2009; 106:11709–11712..
Govorkova EA et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrobial Agents and Chemotherapy, 2009; 53 (7): 3088-3096.
Ilyushina NA et al. Readaptation of a low-virulence influenza H9 escape mutant in mice:the role of changes in hemagglutinin as revealed by site-specific mutagenesis. Archives in Virology.
White NJ et al. What is the optimal therapy for patients with H5N1 influenza? PLoS Med. 2009; 6 (6):e1000091.
Jang H et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA.
Jang H et al. Viral Parkinsonism. Biochim Biophys Acta. 1792:714-21.
Chan RW et al. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrobial Agents and Chemotherapy 53: 3935–3941.
Peiris JS et al. Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol. 2009 Oct 26. [Epub ahead of print] PubMed PMID: 19864182.
Mok KP et al. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J Infect Dis. 2009 Oct 1;200(7):1104-12. PubMed PMID: 19694514.
Li OT et al. One step closer to universal influenza epitopes. Expert Rev Anti Infect Ther. 2009; 7:687-90.
Poon LL et al. Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays. Clin Chem. 2009; 55:1555-8.
Poon LL et al. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol. 2009; 182:3063-71.
Doherty PC et al. Immunity to avian influenza A viruses. Rev Sci Tech. 2009 Apr;28(1):175-85.
Reed ML et al. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. Journal of Virology, 2009; 83:3568-80.
Gaur AH et al. Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza. N Engl J Med. 2010 Jan 7;362(1):88-9. Epub 2009 Dec 23.
Loeb M et al. Surgical mask versus N95 respirator for preventing influenza: a randomized trial. JAMA 2009 Oct 1. Epub ahead of print.
Peiris JSM et al. A novel H1N1 virus causes the first pandemic of the 21st century. European Journal of Immunology 2009; 39: 1–9.
Peiris JS et al. Emergence of a novel swine-origin influenza A virus (SOIV) H1N1 virus in humans. Journal of Clinical Virology 2009; 45: 169–173.
Chan KH et al. Analytical sensitivity of rapid influenza antigen detection tests for swine-origin influenza virus (H1N1). J Clin Virol. 2009 Jul; 45(3):205-7.
Salomon R et al. The Influenza virus enigma. Cell. 2009 Feb 6; 136(3):402-410.
Forrest HL et al. Single- and multiple-clade influenza A H5N1 vaccines induce crossprotection in ferrets. Vaccine. Volume 27, Issue 31, 24 June 2009, Pages 4187-4195
Bahl J et al. Gene flow and competitive exclusion in avian influenza A virus. Virology. 2009 Aug 1;390(2):289-97. Epub 2009 Jun 5.
Marjuki H et al. Isolation of highly pathogenic avian influenza H5N1 virus from Saker falcons 31(Falco cherrug) in the Middle East. Advances in Virology, Volume 2009 (2009), Article ID 294520; doi:10.1155/2009/294520.
Lee JH et al. Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol. 2009 Feb 18.
Santhia K et al. Avian influenza A H5N1 infections in Bali province, Indonesia: a behavioral, virological and seroepidemiological study. Influenza Other Respi Viruses. 2009 May;3(3):81-9
Zhu HC et al. Detection of diverse astroviruses from bats in China. Journal of General Virology 90: 883–887.
Smith GJD et al. Characterization of Avian Influenza Viruses A (H5N1) from Wild Birds, Hong Kong, 2004-2008. Emerging Infectious Diseases 15: 402–407.
Ellis TM et al. Analysis of H5N1 avian influenza infections from wild bird surveillance in Hong Kong from January 2006 to October 2007. Avian Pathology 38: 107–119.
Govorkova EA et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrobial Agents and Chemotherapy, July 2009, p. 3088-3096, Vol. 53, No. 7
Varich NL et al. Location of antigenic sites recognized by monoclonal 74 antibodies in the influenza A virus nucleoprotein molecule. J Gen Virol. 2009 Mar18.
Wan H et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE Aug 12; 3(8): e2923.
Ma W et al. The pig as a mixing vessel for influenza viruses: Human and Veterinary Implications. Journal of Molecular and Genetic Medicine. 3(1), 158-166. (PDF)
Li OT et al. A Full Factorial Analysis of Compatibility between Mammalian and Avian Influenza Polymerase Subunits. PLoS ONE 4(5): e5658. doi:10.1371/journal.pone.0005658
Aldridge JR Jr. et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):5306-11. Epub 2009 Mar 11.
Thomas PG et al. The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1. Immunity. 2009 Apr; 30(4):566-75.
Reed ML et al. Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. Journal of Virology, April 2009, p. 3568-3580, Vol. 83, No. 8.
Yen HL et al. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):286-91. Epub 2008 Dec 30.
Khalenkov A et al. Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology. 2009 Jan 5;383(1):32-8. Epub 2008 Nov 7.
Sandbulte MR et al. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology. 2008 Nov 10;381(1):22-8. Epub 2008 Sep 17.
Ilyushina NA et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother. 2008 Nov;52(11):3889-97. Epub 2008 Aug 25.
Boltz DA et al. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice. Antiviral Res. 2008 Nov;80(2):150-7. Epub 2008 Jun 23.
Kim JK et al. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol. 2008 Nov;82(22):11374-82. Epub 2008 Sep 10.
Duan L et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology. 2008 Oct 25;380(2):243-54. Epub 2008 Sep 6.
Vijaykrishna D et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog. 2008 Sep 26;4(9):e1000161.
Marjuki H et al. CK2beta gene silencing increases cell susceptibility to influenza A virus infection resulting in accelerated virus entry and higher viral protein content. J Mol Signal. 2008 Jul 23;3:13.
Chu DK et al. Novel astroviruses in insectivorous bats. J Virol. 2008 Sep;82(18):9107-14. Epub 2008 Jun 11.
Al-Azemi A et al. Avian influenza A virus (H5N1) outbreaks, Kuwait, 2007. Emerg Infect Dis. 2008 Jun;14(6):958-61.
Chu DK et al. Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats. J Gen Virol. 2008 May;89(Pt 5):1282-7.
Boltz DA et al. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model. J Infect Dis. 2008 May 1;197(9):1315-23.
Ilyushina NA et al. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog. 2008 Apr 11;4(4):e1000043.
Dung Nguyen T et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis. 2008 Apr;14(4):632-6.
Wang J et al. Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China. J Virol. 2008 Apr;82(7):3405-14. Epub 2008 Jan 23.
Khalenkov A et al. Detection and isolation of H5N1 influenza virus from large volumes of natural water. J Virol Methods. 2008 Apr;149(1):180-3. Epub 2008 Mar 5.
Ng SS et al. Heterologous influenza vRNA segments with identical non-coding sequences stimulate viral RNA replication in trans. Virol J. 2008 Jan 11;5:2.
Lipatov AS et al. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo. Arch Virol. 2008;153(3):427-34. Epub 2007 Dec 4.
Ma W et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20949-54. Epub 2007 Dec 18.
Marjuki H et al. Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol J. 2007 Dec 5;4:134.
Kaverin NV et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol. 2007 Dec;81(23):12911-7. Epub 2007 Sep 19.
Boon AC et al. Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis. 2007 Nov;13(11):1720-4.
Yen HL et al. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol. 2007 Nov;81(22):12418-26. Epub 2007 Sep 12.
Fasina FO et al. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis. 2007 Nov;7(11):696-7. No abstract available.
Krauss S et al. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog. 2007 Nov;3(11):e167.
Xu KM et al. The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol. 2007 Oct;81(19):10389-401. Epub 2007 Jul 25.
Cheung CL et al. Establishment of influenza A virus (H6N1) in minor poultry species in southern China. J Virol. 2007 Oct;81(19):10402-12. Epub 2007 Jul 25.
Leung YH et al. Poultry drinking water used for avian influenza surveillance. Emerg Infect Dis. 2007 Sep;13(9):1380-2.
Salomon R et al. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle. 2007 Aug;6(19):2417-21. Epub 2007 Jul 22.
Salomon R et al. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12479-81. Epub 2007 Jul 17.
Duan L et al. Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. J Virol. 2007 Jul;81(14):7529-39. Epub 2007 May 16.
Yen HL et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol. 2007 Jul;81(13):6890-8. Epub 2007 Apr 25.
Evseenko VA et al. Diversity of highly pathogenic avian influenza H5N1 viruses that caused epizootic in Western Siberia in 2005. Dokl Biol Sci. 2007 May-Jun;414:226-30. No abstract available.
Aamir UB et al. Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virology. 2007 Apr 25;361(1):45-55. Epub 2006 Dec 8.
Humberd J et al. Emergence of influenza A virus variants after prolonged shedding from pheasants. J Virol. 2007 Apr;81(8):4044-51. Epub 2007 Jan 31.
Lee YJ et al. Continuing evolution of H9 influenza viruses in Korean poultry. Virology. 2007 Mar 15;359(2):313-23. Epub 2006 Oct 23.
Kumar M et al. Association of serologic and protective responses of avian influenza vaccines in chickens. Avian Dis. 2007 Mar;51(1 Suppl):481-3.
Xu KM et al. Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol. 2007 Mar;81(6):2635-45. Epub 2006 Dec 27.
Ilyushina NA et al. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther. 2007;12(3):363-70.
Boltz DA et al. H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis. 2006 Oct;12(10):1593-5.
Chen X et al. Avian influenza A (H5N1) infection in a patient in China, 2006. Influenza Other Respi Viruses. 2007 Sep-Nov;1(5-6):207-13.
Ma W et al. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol. 2010 Feb;84(4):2122-33. Epub 2009 Dec 9.Emerg Infect Dis. 2006 Oct;12(10):1593-5.
Lau EH et al. Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis. 2007 Sep;13(9):1340-7.Emerg Infect Dis. 2006 Oct;12(10):1593-5.
Forrest HL, Kim JK, Webster RG. Virus shedding and potential for interspecies waterborne transmission of highly pathogenic H5N1 influenza virus in sparrows and chickens. J Virol. 2010 Apr;84(7):3718-20. Epub 2010 Jan 20.
Loeb M et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010 Mar 10;303(10):943-50.
Last Updated January 31, 2011
Last Reviewed May 14, 2010